MRK - Merck & Co., Inc.

NYSE - NYSE Delayed price. Currency in USD

Merck & Co., Inc.

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States
908 740 4000
http://www.merck.com

SectorHealthcare
IndustryDrug Manufacturers—General
Full-time employees71,000

Key executives

NameTitlePayExercisedYear born
Mr. Kenneth C. FrazierChairman, Pres & CEO7.58M26.47M1955
Mr. Robert M. DavisExec. VP of Global Services & CFO2.55MN/A1967
Ms. Jennifer L. ZacharyExec. VP, Gen. Counsel & Corp. Sec.2.11MN/A1978
Dr. Roger M. PerlmutterExec. VP & Pres of Merck Research Laboratories2.75M6.82M1952
Mr. Peter Dannenbaum CFAVP of Investor RelationsN/AN/AN/A
Amounts are as of 31 December 2018, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Merck & Co., Inc. provides healthcare solutions worldwide. It operates through Pharmaceutical and Animal Health segments. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It also provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. It primarily has collaborations with AstraZeneca PLC; Bayer AG; and Eisai Co., Ltd. The company serves drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Corporate governance

Merck & Co., Inc.’s ISS governance QualityScore as of 4 December 2019 is 3. The pillar scores are Audit: 1; Board: 7; Shareholder rights: 2; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more